CMT Research Foundation Invests in Asha Therapeutics to Test Novel Drug for CMT2A
ATLANTA, GA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- CMT Research Foundation has invested in a research project with Asha Therapeutics to investigate the therapeutic potential of inhibiting SARM1 (Sterile alpha and TIR motif-containing protein …